Telomerase mRNA expression and immunohistochemical detection as a biomarker of malignant transformation in patients with inflammatory bowel disease;Detección immunohistoquímica y expresión del ARN de la telomerasa como marcador biológico de transformación neoplásica en pacientes con enfermedad intestinal inflamatoria

Gastroenterologia y Hepatologia

Volumn 33, Issue 4, 2010, Pages 288-296

  Gonzalo, Victoria ^a   Petit, Anna ^a   Castellví Bel, Sergi ^a   Pellisé, Maria ^a   Muñoz, Jenifer ^a   Piñol, Carme ^b   Rodríguez Moranta, Francisco ^a   Clofent, Joan ^c   Balaguer, Francesc ^a   Giráldez, M Dolores ^a   Ocaña, Teresa ^a   Serradesanferm, Anna ^a   Grau, Jaume ^d   Reñé, Josep M ^b   Panés, Julián ^a   Castells, Antoni ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Biomarkers; Colorectal neoplasms; Prevention; Surveillance; Telomerase

Indexed keywords

BIOLOGICAL MARKER; FORMALDEHYDE; MESSENGER RNA; PARAFFIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CLINICAL ARTICLE; COLON CROHN DISEASE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE DURATION; DISEASE MARKER; DYSPLASIA; ENTERITIS; ENZYME ASSAY; FEMALE; FROZEN SECTION; GENE OVEREXPRESSION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CELL TRANSFORMATION, NEOPLASTIC; COLONOSCOPY; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; ENZYME INDUCTION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; RISK; RNA, MESSENGER; SINGLE-BLIND METHOD; TELOMERASE; TIME FACTORS;

EID: 77953083068     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2009.12.011     Document Type: Article

References (37)

1. Crohn B., Rosenberg H. The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am J Med Sci 1925, 170:220-228.
2. Warren S., Sommers S. Cicatrizing enteritis (regional enteritis) as a pathologic entity: analysis of one hundred and twenty cases. Am J Pathol 1948, 24:475-501.
3. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
4. Jess T., Gamborg M., Matzen P., Munkholm P., Sorensen T.I. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 2005, 100:2724-2729.
5. Canavan C., Abrams K.R., Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 2006, 23:1097-1104.
6. von Roon A.C., Reese G., Teare J., Constantinides V., Darzi A.W., Tekkis P.P. The risk of cancer in patients with Crohn's disease. Dis Colon Rectum 2007, 50:839-855.
7. Itzkowitz S.H., Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004, 126:1634-1648.
8. Gupta R.B., Harpaz N., Itzkowitz S., Hossain S., Matula S., Kornbluth A., et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007, 133:1099-1105.. [quiz 1340-1].
9. Price C.M. Telomeres and telomerase: broad effects on cell growth. Curr Opin Genet Dev 1999, 9:218-224.
10. Rhyu M.S. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995, 87:884-894.
11. Shay J.W., Wright W.E. Telomerase activity in human cancer. Curr Opin Oncol 1996, 8:66-71.
12. Nakayama J., Tahara H., Tahara E., Saito M., Ito K., Nakamura H., et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998, 18:65-68.
13. Zou Y., Sfeir A., Gryaznov S.M., Shay J.W., Wright W.E. Does a sentinel or a subset of short telomeres determine replicative senescence?. Mol Biol Cell. 2004, 15:3709-3718.
14. Risques R.A., Lai L.A., Brentnall T.A., Li L., Feng Z., Gallaher J., et al. Is ulcerative colitis a disease of accelerating colon aging? Evidence from telomere attrition and DNA damage. Gastroenterology 2008, 135:410-418.
15. Chambers W.M., Warren B.F., Jewell D.P., Mortensen N.J. Cancer surveillance in ulcerative colitis. Br J Surg 2005, 92:928-936.
16. O'Sullivan J.N., Bronner M.P., Brentnall T.A., Finley J.C., Shen W.T., Emerson S., et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002, 32:280-284.
17. Yan P., Benhattar J., Seelentag W., Stehle J.C., Bosman F.T. Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 2004, 121:391-397.
18. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the Method. Methods 2001, 25:402-408.
19. Yan P., Benhattar J., Seelentag W., Stehle J.C., Bosman F.T. Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 2004, 121:391-397.
20. Brustmann H. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT), topoisomerase IIalpha expression, and apoptosis in endometrial adenocarcinoma and atypical hyperplasia. Int J Gynecol Pathol 2005, 24:184-192.
21. Wick M., Zubov D., Hagen G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 1999, 232:97-106.
22. Wu Y.L., Dudognon C., Nguyen E., Hillion J., Pendino F., Tarkanyi I., et al. Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths. J Cell Sci 2006, 119:2797-2806.
23. Khurts S., Masutomi K., Delgermaa L., Arai K., Oishi N., Mizuno H., et al. Nucleolin interacts with telomerase. J Biol Chem 2004, 279:51508-51515.
24. Breslow R.A., Shay J.W., Gazdar A.F., Srivastava S. Telomerase and early detection of cancer: a National Cancer Institute workshop. J Natl Cancer Inst 1997, 89:618-623.
25. Li C., Wu M.Y., Liang Y.R., Wu X.Y. Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma. World J Gastroenterol 2003, 9:2395-2399.
26. Sun P.M., Wei L.H., Luo M.Y., Liu G., Wang J.L., Mustea A., et al. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2007, 130:249-257.
27. Lam A.K., Saleh S., Smith R.A., Ho Y.H. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity. Hum Pathol 2008, 39:1229-1233.
28. Nosho K., Irahara N., Shima K., Kure S., Kirkner G.J., Schernhammer E.S., et al. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS ONE 2008, 3:e3698.
29. Ahlquist D.A., Sargent D.J., Loprinzi C.L., Levin T.R., Rex D.K., Ahnen D.J., et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008, 149:441-450.
30. Imperiale T.F., Ransohoff D.F., Itzkowitz S.H., Turnbull B.A., Ross M.E. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004, 351:2704-2714.
31. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. Ann Intern Med 2008, 149:627-637. US Preventive Services Task Force.
32. Rutter M.D., Saunders B.P., Wilkinson K.H., Rumbles S., Schofield G., Kamm M.A., et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004, 53:1813-1816.
33. Rutter M.D., Saunders B.P., Wilkinson K.H., Rumbles S., Schofield G., Kamm M.A., et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006, 130:1030-1038.
34. Velayos F.S., Terdiman J.P., Walsh J.M. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 2005, 100:1345-1353.
35. Pardi D.S., Loftus E.V., Kremers W.K., Keach J., Lindor K.D. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003, 124:889-893.
36. Allgayer H., Kruis W. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine. Clin Gastroenterol Hepatol 2006, 4:521.
37. Biasco G., Di Marco M.C. Folate and prevention of colorectal cancer in ulcerative colitis. Eur J Cancer Prev 2005, 14:395-398.